Press Releases

Gilead Sciences to Present at Two Upcoming Investor Conferences

FOSTER CITY, Calif.--(BUSINESS WIRE)--Sept. 1, 2006--Gilead Sciences, Inc. (Nasdaq:GILD)

  • Thomas Weisel Partners Healthcare Tailwinds 2006 Conference on September 6th
  • BioCentury Newsmakers in the Biotech Industry Conference on September 7th
  • Webcasts Available Through Gilead Corporate Website

Gilead Sciences, Inc. (Nasdaq:GILD) announced today that it will be webcasting at two upcoming investor conferences: the Thomas Weisel Partners Healthcare Tailwinds 2006 Conference, in Boston, Massachusetts, and the BioCentury Newsmakers in the Biotech Industry Conference in New York, New York. These webcasts may be accessed via the company's corporate website at

John Martin, Ph.D., Gilead's President and Chief Executive Officer, will provide an overview of the company and an update on key business milestones at the Thomas Weisel Partners conference on Wednesday, September 6th at 10:20 a.m. Eastern Time and at the BioCentury conference on Thursday, September 7th at 2:30 p.m. Eastern Time.

To access the live webcasts via the internet log on to Please connect to the company's website at least 15 minutes prior to each live presentation to ensure adequate time for any software download that may be necessary to listen to the webcast.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

CONTACT: Gilead Sciences, Inc.
Susan Hubbard, 650-522-5715 (Investor Relations)
SOURCE: Gilead Sciences, Inc.